Please join us for a London Life Sciences event by LEDC.
Date: Thursday, March 30th
Timing: 4:30 pm – 6:30 pm
Venue: Trudell Medical International, 725 Baransway Drive, London
Featured speakers include representatives from Sernova, KGK Science, and Trudell Medical.
Registration is limited: https://www.eventbrite.ca/e/life-sciences-london-tickets-585729742427
Andrew Charrette M.Sc. | Director Regulatory Affairs and Psychedelic Advisor
Leading the regulatory affairs division of KGK Science, Andrew Charette brings extensive experience in regulatory processes for clinical trial research and in-depth knowledge of the cannabis regulations in North America. Since joining KGK in 2013, Andrew has led over 50 submissions to Health Canada and consulted on numerous product claims, NDI notifications and GRAS submissions to the U.S. FDA. Andrew received his undergraduate degree in Pharmacology and Physiology from the University of Western Ontario and later obtained a Master’s degree in Neuroscience from the University of Ottawa.
Philip Toleikis, President & CERO, Sernova Corporation
Dr. Toleikis is President and Chief Executive Officer of Sernova Corp since April 2009. While at Sernova, Dr. Toleikis has secured over $60 million in various forms of financings, including equity raises and multiple non-dilutive grants and has been responsible for negotiating a worldwide exclusive license with UHN and University of Miami for its stem cell derived technologies as well as developing business relationships and or collaborations with multiple pharmaceutical and academic institutions involving its Cell Pouch™ device and cell technologies.